Albert Wei of the Alfred Hospital and Monash University in Melbourne, Australia talks about the use of venetoclax plus low-dose cytarabine to treat elderly patients with acute myeloid leukemia. The study found the drug to be safe and clinical remission was achieved in the majority of patients.
Wei A, Strickland SA, Roboz GJ, et al. Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia. Presented at the 58th Annual ASH Meeting & Exposition; San Diego, CA; December 3-6, 2016. Abstract 102